Breaking the Cycle of Bacterial Growth and Resistance
Crestone is a Boulder, Colorado based clinical stage biopharmaceutical company developing new drug candidates with entirely novel mechanisms.
See our progress
Get the latest news
Get to know us
Who We Are
Boulder, Colorado-based Crestone, Inc. is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism of action small molecule drugs for serious bacterial infections. Our pipeline includes antibacterial agents aiming to treat a variety of serious conditions caused by antibacterial-resistant microbes, from C. difficile infection to MRSA, tuberculosis, and more.
Our R&D pipeline includes several programs that address areas of significant and growing unmet medical need, all with novel mechanism of action agents.
Clinical Study 19-0021
A Randomized, Double-blind Evaluation of CRS3123 Versus Oral Vancomycin in Adult Patients with Clostridioides difficile Infection. Phase II is enrolling now—find a clinical site near you and contact the study coordinator to see if you may be eligible to participate!
Oral Session: In vivo Pharmacodynamic Evaluation of CRS0540 in the Murine Thigh and Lung Infection Models against Staphylococcus aureus Poster: Potency of the Novel PolC DNA Polymerase...
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Have a question or comment? Follow the link below to contact us about general inquiries.
Find work in a challenging, team-oriented environment with competitive salaries.
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.